Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline in AstraZeneca PLC Lawsuit

January 09, 2025
AstraZeneca PLC (NASDAQ: AZN) recently faced a class action lawsuit, and The Gross Law Firm is reminding shareholders about an upcoming lead plaintiff deadline of February 21, 2025. The lawsuit alleges that the company made false and misleading statements regarding the effectiveness and safety of one of its drugs. Shareholders who suffered losses are encouraged to join the lawsuit. While this legal battle puts uncertainty on the company, it is important to note that professional stock analysts from Stocks Prognosis have recommended purchasing their stock as they foresee positive movement in the near future.
If you want to leave a comment, then you need Login or Register





Other data for AZN

Related data

AZNSeptember 3, 2025ASTRAZENECA PLC Hits QuantWave Forecast, Generating 16.24% Profit  ~2 min.

ASTRAZENECA PLC has successfully reached the price target forecasted by QuantWave on July 11, 2025. The forecast indicated a long position with a price of 70.64 $....


AZNSeptember 3, 2025ASTRAZENECA PLC Hits 11.81% Profit Target as Forecasted by QuantWave  ~1 min.

ASTRAZENECA PLC's stock has successfully reached the price target forecasted by QuantWave, resulting in a profit of 11.81%. The forecast signal was given on 2025-08-01 when the stock was trading at 73....


AZNSeptember 3, 2025ASTRAZENECA PLC Stock Hits QuantWave Price Target with Profit of 19.38%  ~1 min.

On July 17, 2025, QuantWave, the automated forecasting platform, issued a long signal for ASTRAZENECA PLC stock when it was trading at 68.78 $....


AZNAugust 25, 2025AstraZeneca's Breakthrough Study on Advanced Biliary Tract Cancer  ~1 min.

AstraZeneca PLC has recently announced groundbreaking results from their new study on advanced biliary tract cancer, showing promising potential for a new treatment option in cancer care....


AZNAugust 22, 2025ASTRAZENECA PLC Hits Price Target Forecast with 20.55% Profit  ~1 min.

On January 23, 2025, QuantWave issued a long signal for ASTRAZENECA PLC with a price of 67.17 $. The forecast proved to be accurate as the stock reached the target price of 80....


AZNAugust 22, 2025ASTRAZENECA PLC Stock Hits QuantWave's Price Target Forecast with 14.63% Profit  ~1 min.

ASTRAZENECA PLC stock has successfully reached the price target forecast provided by QuantWave, resulting in a profitable outcome for investors....


AZNAugust 20, 2025ASTRAZENECA PLC Stock Hits Price Target, Yielding 14.58% Profit - QuantWave Prediction Success  ~2 min.

On June 18, 2025, QuantWave issued a long forecast signal for ASTRAZENECA PLC when the stock was trading at $70.27....


AZNAugust 20, 2025ASTRAZENECA PLC Hits Price Target Forecast with 16.44% Profit: A Win for QuantWave  ~1 min.

ASTRAZENECA PLC, one of the leading pharmaceutical companies, has seen its stock price hit the forecasted target with a substantial 16....


AZNAugust 20, 2025ASTRAZENECA PLC Stock Hits Price Target, Generating 13.99% Profit for QuantWave Users  ~2 min.

On July 2, 2025, QuantWave, an automated forecasting platform, issued a price target forecast for ASTRAZENECA PLC with a long signal at a price of 70.64 $....


AZNAugust 20, 2025ASTRAZENECA PLC Hits QuantWave Forecast Target with 15.71% Profit  ~1 min.

On June 26, 2025, QuantWave's automated forecasting platform issued a long signal for ASTRAZENECA PLC with a price target of $80.52. The stock was trading at $69....


AZNJanuary 23, 2025Robbins LLP Encourages AZN Shareholders with Large Losses to Seek Counsel in the AstraZeneca PLC Class Action  ~2 min.

AstraZeneca PLC, a globally renowned pharmaceutical company, is facing a potential setback as Robbins LLP, a leading shareholder rights litigation firm, encourages AZN shareholders with significant losses to seek legal counsel in the AstraZeneca PLC class action. The class action alleges that AstraZeneca PLC made false and misleading statements regarding the efficacy and safety of its COVID-19 vac...


AZNJanuary 15, 2025AstraZeneca PLC Faces Class Action Lawsuit Deadline for Stockholders: Robbins LLP Issues Reminder  ~2 min.

Robbins LLP, a global investor rights law firm, is reminding stockholders of AstraZeneca PLC (AZN) about the upcoming lead plaintiff deadline in the class action lawsuit against the company....


AZNJanuary 25, 2025AstraZeneca PLC Faces Class Action Lawsuit for Investor Recovery  ~2 min.

Robbins LLP, a leading investor rights law firm, is encouraging shareholders of AstraZeneca PLC (AZN) who have suffered significant financial losses to seek legal counsel in the ongoing class action lawsuit against the company. The lawsuit, filed by Levi Korsinsky, aims to recover damages for investors who suffered losses due to alleged misleading statements and omissions made by AstraZeneca regar...


VJanuary 8, 2025Visa Inc. Faces Securities Class Action Lawsuit: Investors Urged to Seek Legal Counsel  ~1 min.

Investors in Visa Inc. (V) are advised to secure legal counsel as the company faces a securities class action lawsuit....


AZNJanuary 26, 2025Class Action Filed Against AstraZeneca PLC AZN Seeking Recovery for Investors  ~1 min.

Robbins LLP Encourages AZN Shareholders with Large Losses to Seek Counsel in the AstraZeneca PLC Class Action....